Evaluation of febrile neutropenic episodes in adult patients with solid tumors. - Wikidata - wikimedia - TriplyDB

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

http://www.wikidata.org/entity/Q34676431

about

Infections in Cancer Patients with Solid Tumors: A Review.Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

P2860

Q30238576-582B6909-06CA-412C-9E4E-3EB8641692D2 Q38747206-850F24C0-C21A-4892-837D-06A639DFB5E0

P2860

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

http://www.wikidata.org/entity/Q34676431

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@ast

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@en

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@nl

type

label

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@ast

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@en

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@nl

prefLabel

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@ast

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@en

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@nl

P1433

Q34676431-21B473BD-5B77-4887-A37A-F5929AFAFF71

P1476

Q34676431-5C8ADAE7-E61B-4D13-A288-8B825B6ADE8A

P2093

Q34676431-216F7BF8-4B49-4497-9858-28240BD544FB

Q34676431-40405442-C553-45D8-AEDE-B02B9F2A5BDE

Q34676431-4AC918A5-D41C-45E8-AE90-D773AA6802B6

Q34676431-59B06913-B822-49E3-BD30-651AF2A9C13E

Q34676431-8293FB8A-9CCE-4AC0-AD96-792E34EB3C66

Q34676431-F00C6F49-BDBE-425B-8894-531F395CB755

P2860

Q34676431-13335B17-C791-4C86-9F61-9C319307B1CB

Q34676431-2BEBD106-2225-49CF-8EB6-CAD1628356E5

Q34676431-4333454D-6CD3-42DA-9AAC-A0E7288831D3

Q34676431-5247F224-4558-4391-9971-8028D60EDB07

Q34676431-5D993AAC-3D8B-4B1A-8589-1674EE13E071

Q34676431-64ADAD39-DDE0-4514-A580-310DC66E87A1

Q34676431-77129272-8829-467E-AF83-739822DED473

Q34676431-7BDCD4E7-D706-4B2D-A7DC-B65911BCFB70

Q34676431-85F20B22-23AC-45CF-8D99-B3025264F066

Q34676431-8644E1DB-A5BF-4735-BB45-AF20FF3F7D38

P304

Q34676431-028A9A7C-3CFB-46D0-9EBB-CA2F0D77E28F

P31

Q34676431-46315116-937B-4FCB-9D07-DC248E8E6704

P356

Q34676431-087FD4E8-7035-42F0-B980-DBFE73161474

P433

Q34676431-B6437DF5-173B-431A-AF1B-E851C4606E5F

P478

Q34676431-46EA3B64-C3AB-4438-AA92-5E6BDFEBF583

P577

Q34676431-D2FF94BD-772C-4420-98DC-70F2B34D97B3

P5875

Q34676431-F17DC125-60E4-419A-8D2F-972207CEF18C

P698

Q34676431-15593C93-DC9E-4249-B6B0-3803CB78FC59

P932

Q34676431-86BF0ED8-31C5-4F82-85D4-D32341F0B0F4

P356

P1433

Molecular and clinical oncology

P1476

Evaluation of febrile neutropenic episodes in adult patients with solid tumors.

@en

P2093

Alparslan Merdin

http://www.w3.org/2001/XMLSchema#string

Fatma Avci Merdin

http://www.w3.org/2001/XMLSchema#string

Filiz Gunseren

http://www.w3.org/2001/XMLSchema#string

Hafize Yapici

http://www.w3.org/2001/XMLSchema#string

Oktay Yapici

http://www.w3.org/2001/XMLSchema#string

Ülkü Üser Yaylali

http://www.w3.org/2001/XMLSchema#string

P2860

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria.

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Risk factors assessment in fabrile neutropenia.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Independent factors for prediction of poor outcomes in patients with febrile neutropenia

Risk assessment and risk-based therapeutic strategies in febrile neutropenia.

Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural

An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.

Risk assessment and treatment of low-risk patients with febrile neutropenia.

P304

379-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2015.722

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288698879

http://www.w3.org/2001/XMLSchema#string

P698

26998287

http://www.w3.org/2001/XMLSchema#string

P932

4774564

http://www.w3.org/2001/XMLSchema#string